Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$331,747,292
+$53,144,226 QoQ
Shares Held
2,581,691
+11.5% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#91
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $5,015,687,266 across 13 Drug Manufacturers - General names. MRK ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,536,227 | $1,429,019,361 | |
| 2 | LLY |
ELI LILLY & Co
|
1,001,608 | $1,201,358,780 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,938,774 | $497,624,704 | |
| 4 | JNJ |
Johnson & Johnson
|
1,657,928 | $421,063,972 | |
| 5 | ABBV |
AbbVie Inc.
|
1,521,377 | $382,839,306 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
2,581,691 | $331,747,292 | |
| 7 | AMGN |
Amgen Inc
|
821,365 | $297,432,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,327,511 | $249,351,182 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $331,747,292 | 2,581,691 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $278,603,066 | 2,316,095 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $279,412,668 | 2,654,500 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $82,102,759 | 978,229 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $101,208,988 | 1,278,537 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $109,157,225 | 1,216,101 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $147,330,775 | 1,481,009 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $160,663,438 | 1,414,789 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $192,849,077 | 1,557,747 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $199,156,356 | 1,509,332 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $117,090,095 | 1,074,024 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $111,357,102 | 1,081,662 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $144,199,420 | 1,249,670 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $162,641,371 | 1,528,728 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $140,650,647 | 1,267,694 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $129,613,786 | 1,505,037 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $115,222,651 | 1,263,822 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $96,957,171 | 1,181,684 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $84,022,730 | 1,096,330 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $66,345,263 | 883,308 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $58,075,057 | 746,754 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $53,093,299 | 688,718 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $72,046,788 | 880,768 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $76,653,631 | 924,094 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $88,665,069 | 1,146,580 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $81,082,799 | 1,053,845 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||